Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
| |
 |
Article |
|
| |
|
|
Selecting an optimized stability plan for your injectable drug product
No matter the indication, molecule, or therapeutic area, every drug developer working on a parenteral medication needs to answer the same essential question: what's the best approach to retaining the product’s stability?
|
|
|
| |
|
How to tackle top healthcare logistics challenges in 2022
Combining the power of network with data paves the way for better logistical support for healthcare players.The latest wave of COVID-19 infections has made its way across East Asia.
|
|
 |
| | | |
| |
 |
News Insights |
|
| |
|
|
Keeping The Risk of Packaging In Check With Kids Involved
Creative packaging designs, especially in case of pharmaceuticals, is the need of the day to avoid kids gaining access to the medicines not suitable for them.
|
|
|
| |
|
Australia Introduces A Fresh Outlook To Stem Cell Production
While this ground-breaking system is still in the prototype stage, UTS is closely collaborating with biotechnology firms to bring the technology to market.
|
|
 |
|
|
| |
| |
|
|
Novartis Announces $250M Funding In R&D For NTDs, Malaria
The focal point of this funding is said to be taking NTDs and Malaria head on, especially the latter which is still responsible for deaths of thousands of kids.
|
|
|
| |
|
GSK Pledges £1 Billion R&D Commitment For The Poor Nations
The research will aim on the development of new drugs and vaccines to combat bacterial infections, malaria, tuberculosis, neglected tropical diseases, and HIV.
|
|
 |
| | | |
| |
 |
COVID-19 Updates |
|
| |
|
|
US FDA Advisers Advocate Changing Fall COVID Vaccine Dosage
FDA experts stated during the meeting that they favoured vaccines that would target the dominant BA.4, BA.5 Omicron subvariants over the BA.1 Omicron variant.
|
|
|
| |
| |
BioNTech And Regulator Differ On COVID Jab Approval- WAS
The new vaccine which has been developed keeping in mind the Omicron variant may get deferred due to a prolonging disagreement because of the approval process.
|
|
|
|
|
| |
| |
|
|
What Is The Reason For A Sluggish African Immunisation Rate?
There has been steady decline in number of COVID-19 vaccinations administered across African population due to lack of planning despite greater accessibility.
|
|
|
| |
| |
Amref, Astrazeneca Build COVID-19 Mobile Clinics In Kenya
By giving vaccine information, COVID-19 screening, safer vaccination, and post-immunization care, mobile clinics will aid in closing the COVID-19 vaccine gap.
|
|
|
|
|
